为中国医疗健康事业书写“乐城方案”

Core Viewpoint - The Boao Lecheng International Medical Tourism Pilot Zone has transformed from a barren land into a modern medical industrial park, aiming to connect international resources with domestic patient needs through innovative policies and practices [2]. Group 1: Development and Achievements - Since its establishment in 2013, Lecheng has introduced 530 types of special drugs and medical devices, benefiting over 200,000 patients [2]. - From January to October 2025, the number of patients using special drugs and devices increased by 137.3%, while the number of medical tourists grew by 81% [2]. - Lecheng has achieved synchronization in medical technology, equipment, and drugs with global standards, enabling patients to receive advanced medical care domestically [2]. Group 2: Policy Innovations - Lecheng has implemented several pioneering national policies, including the approval of 16 cutting-edge technology projects and a zero-tariff policy for imported medical devices, resulting in a total tax exemption of 405 million yuan and a tax reduction of 52.68 million yuan [3]. - The region has utilized real-world clinical data to support the review and approval of medical devices, accelerating the domestic market entry of 21 international innovative drugs and devices [3]. - An expert committee has been established to enhance the evaluation and introduction of international innovative medical devices, promoting a collaborative model for patient care and data sharing [3]. Group 3: Future Prospects - The first Global Innovation Drug and Device Expo attracted nearly 80 foreign pharmaceutical and medical device companies, indicating strong international interest in Lecheng's development [4]. - With the official launch of the Hainan Free Trade Port, Lecheng is poised to transition from a policy hub to a talent and industry hub, aiming to become a world-class international medical tourism destination and medical technology innovation platform [4]. - The region plans to integrate medical services, pharmaceuticals, research, production, and urban development to create a "Health City" that contributes uniquely to China's healthcare sector [4].